| 摘要 |
The invention relates to stabilised pharmaceutical preparations containing thyroid hormone, the stabilising component being sodium thiosulphate and the mass ratio of the thyroid hormone to the sodium thiosulphate being 1:0.1 - 1:50. Also disclosed is a method of producing the pharmaceutical preparations in question. |
